Delivery Order SPE2DB24D8003-SPE2DB25FG65G
Award Date 9/11/25
Potential Completion Date 9/12/25
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded Dakota Drug, Inc. a delivery order valued at $1,578.15 for 100 capsules of lisdexamfetamine 10 mg on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price delivery order is issued without set-aside designation and represents a direct purchase under the company's existing indefinite delivery contract with DLA Troop Support Medical. The work will be performed in Anoka, Minnesota, where Dakota Drug maintains its operations...
- The Defense Logistics Agency awarded a $1,318.02 firm fixed price delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of lisdexamfetamine 50 mg capsules (100-count units). This delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a pharmaceutical procurement under DLA Troop Support Medical's operations. The award carries no set-aside designation and is being performed at Dakota...
- The Defense Logistics Agency awarded a delivery order valued at $2,011.46 to Dakota Drug, Inc., a small disadvantaged business located in Anoka, Minnesota, for the supply of Lisdexamfetamine 50 mg capsules (100-count units). This firm fixed price delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025, and carries no set-aside designation. The award is issued under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,926.97 to Dakota Drug, Inc. for the supply of Lisdexamfetamine 20 mg capsules (100 count) with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a pharmaceutical supply fulfillment under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is Anoka, Minnesota, where Dakota Drug...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,042.84, is for the delivery of 4,567,372,214 lisdexamfetamine 40 mg capsules, to be completed by February 26, 2025. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,229.69 firm fixed price delivery order is for the supply of 100 units of the medication lisdexamfetamine 60 mg capsules. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The award, with a contract number of SPE2DB24D8002|SPE2DB25FJNDD, is for the delivery of 4,567,235 units of 50 mg lisdexamfetamine capsules. The contract has a firm fixed-price delivery order type with a ceiling value of $1,350.58 and a completion date of February 12, 2025. Dakota Drug, Inc. is also the holder of a significant single-award Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of lisdexamfetamine 50 mg capsules, a pharmaceutical product. The contract has a ceiling value of $2,326.86 and a completion date of December 18, 2024. This contract is not set aside for any special designation. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, identified as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,000.64, is for the delivery of 4566862011 - LISDEXAMFETAMINE 40 MG CAPSULE 100S to support U.S. Armed Forces medical operations. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2025. It is not a set-aside contract. Dakota Drug, Inc. is a key supplier for the DLA Troop...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $1,161.78, is for the delivery of VYVANSE 40 MG CAPSULE 100S. The contract has an ultimate completion date of July 18, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...